Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,551 | 35,617 | 96,494 | 22,465 | 21,116 |
| Marketable Securities | 223,818 | 274,347 | 259,104 | 147,561 | 197,311 |
| Receivables | 2,895 | 2,620 | 1,526 | 1,010 | 318 |
| Inventories | 636 | 585 | 514 | 381 | 336 |
| TOTAL | $268,606 | $320,844 | $364,647 | $176,547 | $223,372 |
| Non-Current Assets | |||||
| PPE Net | 2,135 | 1,954 | 1,843 | 1,987 | 2,134 |
| Intangibles | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 |
| Other Non-Current Assets | 5,839 | 6,015 | 6,186 | 6,352 | 6,430 |
| TOTAL | $52,517 | $52,512 | $52,572 | $52,882 | $53,107 |
| Total Assets | $321,123 | $373,356 | $417,219 | $229,429 | $276,479 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,201 | 12,220 | 8,067 | 14,389 | 12,036 |
| Accrued Expenses | 21,845 | 15,656 | 15,332 | 17,157 | 20,225 |
| TOTAL | $36,046 | $27,876 | $23,399 | $31,546 | $32,261 |
| Non-Current Liabilities | |||||
| Long Term Debt | 99,895 | 99,499 | 99,874 | 99,508 | 99,265 |
| Other Non-Current Liabilities | 6,670 | 6,001 | 5,079 | 5,265 | 5,443 |
| TOTAL | $106,565 | $105,500 | $104,953 | $104,773 | $104,708 |
| Total Liabilities | $142,611 | $133,376 | $128,352 | $136,319 | $136,969 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 361,492 | 361,492 | 246,237 | 246,237 | 244,925 |
| Common Shares | 363 | 363 | 248 | 245 | 245 |
| Retained earnings | -1,933,476 | -1,868,665 | -1,815,236 | -1,766,839 | -1,717,083 |
| Other shareholders' equity | 734 | 192 | 358 | 146 | 2 |
| TOTAL | $178,512 | $239,980 | $288,867 | $93,110 | $139,510 |
| Total Liabilities And Equity | $321,123 | $373,356 | $417,219 | $229,429 | $276,479 |